Checchi Capital Advisers LLC Sells 3,149 Shares of Lam Research Corporation $LRCX

Checchi Capital Advisers LLC cut its holdings in Lam Research Corporation (NASDAQ:LRCX) by 17.9% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 14,417 shares of the semiconductor company’s stock after selling 3,149 shares during the quarter. Checchi Capital Advisers LLC’s holdings in Lam Research were worth $1,930,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. IMG Wealth Management Inc. bought a new stake in shares of Lam Research in the 2nd quarter valued at about $26,000. Howard Hughes Medical Institute bought a new stake in Lam Research in the second quarter valued at approximately $27,000. Strategic Wealth Investment Group LLC acquired a new stake in Lam Research in the second quarter worth $29,000. Delos Wealth Advisors LLC bought a new position in shares of Lam Research during the second quarter worth $30,000. Finally, REAP Financial Group LLC acquired a new position in shares of Lam Research in the 2nd quarter valued at $31,000. Institutional investors own 84.61% of the company’s stock.

Insider Transactions at Lam Research

In other Lam Research news, CFO Douglas R. Bettinger sold 40,080 shares of Lam Research stock in a transaction on Friday, November 14th. The shares were sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the completion of the transaction, the chief financial officer directly owned 987,237 shares of the company’s stock, valued at $148,677,892.20. The trade was a 3.90% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.31% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several analysts recently commented on LRCX shares. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $320.00 price objective (up previously from $265.00) on shares of Lam Research in a research note on Thursday, January 29th. Mizuho set a $265.00 price target on Lam Research in a research report on Wednesday, January 28th. Citic Securities lifted their price objective on Lam Research from $165.00 to $275.00 and gave the company a “buy” rating in a report on Friday, January 30th. Evercore ISI set a $275.00 target price on Lam Research in a research note on Thursday, January 29th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on shares of Lam Research from $260.00 to $290.00 and gave the company a “buy” rating in a research note on Thursday, January 29th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-eight have assigned a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $243.32.

Lam Research News Summary

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Company leadership changes intended to accelerate AI‑era execution — Lam promoted two senior leaders to increase velocity as it leans into AI-driven demand, a governance move investors typically view as supportive for execution and strategy. Lam Research Announces Leadership Transitions to Increase Company Velocity for the AI era
• Positive Sentiment: Cadence CEO Anirudh Devgan added to the board — brings software/EDA and customer insight, which strengthens board expertise as Lam targets AI and advanced-node investments. Lam Research Appoints Cadence CEO Anirudh Devgan to Board of Directors
• Positive Sentiment: Expanded R&D partnership with CEA‑Leti to accelerate specialty technologies and AI‑focused chip work — supports Lam’s longer‑term TAM expansion into MEMS, photonics, sensors and other specialty devices that benefit from advanced deposition/etch equipment. Lam Research and CEA-Leti Expand Research and Development Collaboration to Advance Fabrication of Specialty Technologies
• Positive Sentiment: Analyst price‑target lifts are supporting the bull case — Argus raised its target to $280 and B. Riley raised/ reiterated a higher target (to $310), signaling strong analyst confidence that could underpin shares over time. Argus Research Adjusts Lam Research Price Target to $280 B. Riley Lifts PT on Lam Research to $310
• Neutral Sentiment: Analytical pieces on international revenue trends and Wall Street sentiment — useful context for modeling growth and geographic exposure but not immediate catalysts. Don’t Overlook Lam Research (LRCX) International Revenue Trends While Assessing the Stock
• Neutral Sentiment: Long‑term performance retrospectives and modest PT moves — articles highlighting 15‑year returns and a smaller PT raise to $235 provide background for buy‑and‑hold investors but are not near‑term drivers. $100 Invested In Lam Research 15 Years Ago Would Be Worth This Much Today Lam Research Price Target Raised to $235
• Negative Sentiment: Sector/peer commentary (KLA) has introduced confusion and volatility — differing WFE-market definitions and headline interpretations after KLA’s earnings prompted selling in the equipment group, which can drag on Lam even if Lam’s own outlook is strong. KLA Sank After Earnings—Then Analysts Started Raising Targets
• Negative Sentiment: Relative performance concerns — headlines noting Lam underperformed some peers recently can trigger short‑term profit‑taking and pressure the stock while investors reconcile earnings/guidance with peer messaging. Lam Research Corp. stock underperforms Monday when compared to competitors despite daily gains

Lam Research Price Performance

Shares of NASDAQ LRCX opened at $230.10 on Wednesday. Lam Research Corporation has a fifty-two week low of $56.32 and a fifty-two week high of $251.87. The stock has a market capitalization of $287.34 billion, a price-to-earnings ratio of 47.15, a PEG ratio of 2.59 and a beta of 1.78. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.26 and a quick ratio of 1.61. The business has a 50-day moving average of $190.60 and a 200-day moving average of $148.53.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share for the quarter, beating analysts’ consensus estimates of $1.17 by $0.10. The firm had revenue of $5.34 billion during the quarter, compared to the consensus estimate of $5.23 billion. Lam Research had a return on equity of 62.81% and a net margin of 30.22%.The business’s revenue was up 22.1% compared to the same quarter last year. During the same period last year, the company earned $0.91 earnings per share. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. As a group, sell-side analysts predict that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Company Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.